In his weekly clinical update, Dr. Griffin discusses the effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19–associated hospitalizations in infants aged

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19–associated hospitalizations in infants (CDC)
• COVID-19 vaccination recommendations and practices for women of reproductive age (CDC)
• Molnupiravir for intra-household prevention of COVID-19 (JOI)
• Delayed peak SARS-CoV-2 viral loads relative to symptom onset and implications for COVID-19 testing programs
• Viral kinetics of sequential SARS-CoV-2 infections (Nature)
• FDA authorizes updated Novavax COVID-19 vaccine (FDA)
• Antiviral efficacy of molnupiravir vs ritonavir/nirmatrelvir in patients with COVID-19 (The Lancet)
• Long-term cardiovascular, cerebrovascular, and other thrombotic complications in COVID-19 survivors (CID)
• SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in coronary vessels (NCR)
• Efficacy of gabapentin For Post–COVID-19
• Contribute to our Floating Doctors fundraiser at PWB
• Letters read on TWiV 1050
• Dr. Griffin's COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]